Physician's Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 17 to 21, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Meds Used for Hospitalized COVID-19 Patients Shifted Over 2020
FRIDAY, May 21, 2021 -- In 2020, there were marked shifts in the therapeutics used to treat hospitalized COVID-19 patients, according to a research letter published online May 21 in JAMA Network Open.
Approved Vaccines 'Respond' to All COVID-19 Variants So Far: WHO
FRIDAY, May 21, 2021 -- Vaccines approved for use in the United States and Europe show protection against all of the more infectious coronavirus variants known to be circling the globe, the World Health Organization said Thursday.
FDA Eases Storage Rules for Pfizer COVID-19 Vaccine
THURSDAY, May 20, 2021 -- New storage rules for the Pfizer COVID-19 vaccine after it has been thawed that will make it easier to transport and deliver the doses have been announced by the U.S. Food and Drug Administration.
COVID-19 Booster Shots Likely Needed Within a Year: Fauci
THURSDAY, May 20, 2021 -- Fully vaccinated people will likely need a COVID-19 booster shot within about a year, the nation's top infectious diseases expert and the Pfizer CEO said Wednesday.
SARS-CoV-2 Seropositivity Not Associated With Low Vitamin D
THURSDAY, May 20, 2021 -- Severe acute respiratory syndrome coronavirus 2 seropositivity is not associated with low vitamin D levels, according to a study published online May 19 in JAMA Network Open.
Presentation of Multisystem Inflammatory Syndrome Varies in Adults
THURSDAY, May 20, 2021 -- Patients with multisystem inflammatory syndrome in adults after severe acute respiratory syndrome coronavirus 2 infection have a heterogeneous clinical presentation, according to a research letter published online May 19 in JAMA Network Open.
About 1 Million Excess Deaths Reported in 29 High-Income Countries in 2020
THURSDAY, May 20, 2021 -- In 29 high-income countries, there were about 1 million excess deaths in 2020, according to a study published online May 19 in The BMJ.
COVID-19 Pandemic Tied to Increase in Overdose Deaths
THURSDAY, May 20, 2021 -- There was an increase in drug overdose deaths in San Francisco during the COVID-19 pandemic, according to a research letter published online May 12 in JAMA Network Open.
Hospitalization Rates Overestimate COVID-19 Burden in Children
WEDNESDAY, May 19, 2021 -- Reported hospitalization rates overestimate the burden of COVID-19 in children, according to a study published online May 19 in Hospital Pediatrics.
Fully Vaccinated Travelers Can Soon Visit EU Countries
WEDNESDAY, May 19, 2021 -- The fully vaccinated will soon be welcome to visit countries in the European Union, officials there announced Wednesday.
Less Than 1 Percent of COVID-19 Patients Experience Recurrence
WEDNESDAY, May 19, 2021 -- For every 10,000 confirmed COVID-19 cases, there are approximately 4.3 recurrent cases, according to a study published online May 4 in PLOS ONE.
Venous Thromboembolic Event Rates Up With ChAdOx1-S Vaccine
WEDNESDAY, May 19, 2021 -- The rates of venous thromboembolic events, including cerebral venous thrombosis, are increased among recipients of the Oxford-AstraZeneca vaccine ChAdOx1-S, although the absolute rates are small, according to a study published online May 5 in The BMJ.
mRNA Vaccines Effective for Preventing Symptomatic COVID-19
TUESDAY, May 18, 2021 -- For health care personnel, the vaccine effectiveness of authorized mRNA COVID-19 vaccines (Pfizer-BioNTech and Moderna) against symptomatic COVID-19 illness is 82 and 94 percent for a single dose and for two doses, respectively, according to research published in the May 14 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Ohio Lottery Will Award $1 Million to Five Vaccinated Residents
TUESDAY, May 18, 2021 -- In an effort to boost COVID-19 vaccination numbers, Ohio officials said they will hold a weekly lottery in which five adult residents who have received at least their first dose of a vaccine will receive $1 million each.
Infliximab May Reduce Immunogenicity to SARS-CoV-2 Vaccine
TUESDAY, May 18, 2021 -- Individuals with inflammatory bowel disease who are treated with infliximab rather than vedolizumab have reduced immunogenicity to a single dose of BNT162b2 and ChAdOx1 nCoV-19 severe acute respiratory syndrome coronavirus 2 vaccines, according to a study published online April 26 in Gut.
After Setbacks, Sanofi/GSK COVID-19 Vaccine Performs Well in Early Trial
TUESDAY, May 18, 2021 -- Sanofi and GlaxoSmithKline announced Monday that their COVID-19 vaccine candidate produced powerful responses in a preliminary trial that followed an earlier setback in the vaccine's development.
Hepatitis C Testing, Treatment Down During the Pandemic
MONDAY, May 17, 2021 -- The COVID-19 pandemic reduced routine hepatitis C virus testing and treatment, according to a study published online May 10 in the American Journal of Preventive Medicine.
CDC Director Says New Mask Guidance Is Based on Science
MONDAY, May 17, 2021 -- The decision to ease mask rules for fully vaccinated Americans is based on science and not political pressure, the director of the U.S. Centers for Disease Control and Prevention told media outlets on Sunday.
Most Japanese Want Olympic Games Delayed or Canceled: Poll
MONDAY, May 17, 2021 -- More than eight in 10 people in Japan do not want their country to host the Olympics this summer, according to a poll conducted on the weekend as the nation combats a fourth COVID-19 wave.
Systemic Reactogenicity Up With Heterologous COVID-19 Vaccine Doses
MONDAY, May 17, 2021 -- Participants receiving heterologous prime and boost doses of COVID-19 vaccines have an increase in systemic reactogenicity after the boost dose compared with those receiving homologous vaccine schedules, according to a research letter published online May 12 in The Lancet.
Risk for Severe Effects Low After SARS-CoV-2 Without Hospitalization
MONDAY, May 17, 2021 -- The risk for severe postacute complications is low after severe acute respiratory syndrome coronavirus 2 infection not requiring hospitalization, according to a study published online May 10 in The Lancet Infectious Diseases.
© 2021 HealthDay. All rights reserved.
Posted: May 2021